Cycurion, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets: | ||
| Cash and cash equivalents | $2,028,718 | $5,255,235 |
| Accounts receivable, net | 3,336,047 | 2,687,479 |
| Prepaid expenses and other current assets | 106,934 | 60,133 |
| Total current assets | 5,471,699 | 8,002,847 |
| Software development costs, net | 4,735,981 | 4,606,981 |
| Goodwill | 21,238,450 | 20,842,508 |
| Total non-current assets | 25,974,431 | 25,449,489 |
| Total assets | $31,446,130 | $33,452,336 |
| Liabilities and Stockholders' Equity: | ||
| Liabilities: | ||
| Bank loan-revolving credit line | $2,725,546 | $2,933,396 |
| Loans payable - current portion | 669,693 | 669,693 |
| Factoring liability | 1,566,887 | 1,511,678 |
| Convertible notes | 192,897 | 192,897 |
| Promissory notes | 2,500,849 | 2,499,662 |
| Loans payable - related parties | 123,650 | 123,650 |
| Accounts payable | 1,441,596 | 1,314,772 |
| Accrued liabilities | 4,283,045 | 4,228,337 |
| Accrued compensation and benefits | 1,306,906 | 919,825 |
| Accrued interest payable | 1,486,041 | 1,347,787 |
| Excise tax payable | 1,167,173 | 1,167,173 |
| Total current liabilities | 17,464,283 | 16,908,870 |
| Loans payable - non-current portion | 300,000 | 300,000 |
| Total non-current liabilities | 300,000 | 300,000 |
| Total liabilities | 17,764,283 | 17,208,870 |
| Commitments and contingencies (Note 19) | ||
| Stockholders' Equity: | ||
| Preferred stock ($0.0001 par value, 20,000,000 shares authorized) | ||
| Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 1 issued and outstanding, respectively) | - | - |
| Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 2,547 and 4,851 issued and outstanding, respectively) | - | - |
| Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 150,000 issued and outstanding, respectively) | 15 | 15 |
| Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 51 issued and outstanding, respectively) | - | - |
| Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 143 and 143 issued and outstanding, respectively) | - | - |
| Common stock ($0.0001 par value, 300,000,000 shares authorized, 5,510,021 and 3,642,501 shares issued and outstanding, respectively) | 551 | 364 |
| Additional paid in capital | 46,979,742 | 46,979,762 |
| Accumulated deficit | (29,007,543) | (26,879,081) |
| Total stockholders' equity attributable to Cycurion | 17,972,765 | 20,101,060 |
| Deficit attributable to noncontrolling interests | (4,290,918) | (3,857,594) |
| Total stockholders' equity | 13,681,847 | 16,243,466 |
| Total liabilities and stockholders’ equity | $31,446,130 | $33,452,336 |
| See accompanying notes to unaudited consolidated financial statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.